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Abstract
Alpha7 nicotinic acetylcholine receptor (nAChR), an essential regulator of inflammation, is abundantly expressed in
hippocampal neurons, which are vulnerable to bacterial meningitis. However, it is unknown whether a7 nAChR contributes
to the regulation of these events. In this report, an aggravating role of a7 nAChR in host defense against meningitic E. coli
infection was demonstrated by using a7-deficient (a7
-/-) mouse brain microvascular endothelial cells (BMEC) and animal
model systems. As shown in our in vitro and in vivo studies, E. coli K1 invasion and polymorphonuclear neutrophil (PMN)
transmigration across the blood-brain barrier (BBB) were significantly reduced in a7
-/- BMEC and a7
-/- mice. Stimulation by
nicotine was abolished in the a7
-/- cells and animals. The same blocking effect was achieved by methyllycaconitine (a7
antagonist). The tight junction molecules occludin and ZO-1 were significantly reduced in the brain cortex of wildtype mice
infected with E. coli and treated with nicotine, compared to a7
-/- cells and animals. Decreased neuronal injury in the
hippocampal dentate gyrus was observed in a7
-/- mice with meningitis. Proinflammatory cytokines (IL-1b, IL-6, TNFa, MCP-1,
MIP-1alpha, and RANTES) and adhesion molecules (CD44 and ICAM-1) were significantly reduced in the cerebrospinal fluids
of the a7
-/- mice with E. coli meningitis. Furthermore, a7 nAChR is the major calcium channel for nicotine- and E. coli K1-
increased intracellular calcium concentrations of mouse BMEC. Taken together, our data suggest that a7 nAChR plays a
detrimental role in the host defense against meningitic infection by modulation of pathogen invasion, PMN recruitment,
calcium signaling and neuronal inflammation.
Citation: Chi F, Wang L, Zheng X, Wu C-H, Jong A, et al. (2011) Meningitic Escherichia coli K1 Penetration and Neutrophil Transmigration Across the Blood–Brain
Barrier are Modulated by Alpha7 Nicotinic Receptor. PLoS ONE 6(9): e25016. doi:10.1371/journal.pone.0025016
Editor: Samithamby Jeyaseelan, Louisiana State University, United States of America
Received June 20, 2011; Accepted August 22, 2011; Published September 22, 2011
Copyright:  2011 Chi et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was financially supported by Public Health Service grants R56-AI40635 (Dr. Huang) and R01-NS047599 (Dr. Jong), a Saban Research Institute
Research Career Development Fellowship (RCDF) (Dr. Chi), and a National Natural Science Foundation grant of China 81070514 (Dr. Wang). The funders had no
role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: shhuang@hsc.usc.edu
. These authors contributed equally to this work.
Introduction
Pathogen penetration and polymorphonuclear neutrophil
(PMN) transmigration across the blood-brain barrier (BBB) are
the hallmark features of bacterial meningitis, which is the most
common serious infection of the central nervous system (CNS) [1-
2]. For disease to develop, blood-borne pathogens must interact
with and penetrate across brain microvascular endothelial cells
(BMEC), which form the main constituents of the BBB, and then
gain access to the brain and meninges. An overwhelming host
inflammatory response, including transendothelial migration of
PMN, is provoked upon bacterial internalization and replication
within the CNS. While various bacterial determinants and CNS
factors that contribute to pathogen invasion, neuronal inflamma-
tion and brain injury have been identified and characterized in
both in vitro and in vivo models of bacterial meningitis, little is
known about the specific contribution of a7 nAChR, an essential
regulator of inflammation, to the pathogenesis of bacterial
meningitis.
Bacterial meningitis most frequently results from the bacter-
emia, which is essential for pathogen invasion across the BBB [1].
There are two important aspects suggested in the gap between the
biology of a7 nAChR and bacterial penetration across the BBB.
On one hand, an important connection between the nervous
system and the inflammatory response to disease has been
uncovered through identification of a7 nAChR as an essential
regulator of inflammation. As reported by Wang et al., the a7
subunit is essential for inhibiting endotoxin-induced cytokine
synthesis in macrophages through the cholinergic anti-inflamma-
tory pathway [3]. Recent studies demonstrated that a7 nAChR
played a detrimental role in the host defense against E. coli
peritonitis and pneumococcal pneumonia [4–5]. The host defense
against bacterial infection is impaired by stimulation of a7 nAChR
with nicotine, which is an a7 agonist derived from tobacco smoke
with multiple effects on the vascular, immune and nervous systems
[5-6]. It is likely that nicotine is able to modulate the host defense
system through nAChRs on cells in the tissue barriers, the immune
system and the CNS similar to opiates and cannabinoids [7]. We
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meningitic E. coli K1 invasion of human BMEC in vitro, suggesting
the involvement of a7 nAChR in the pathogenesis of bacterial
meningitis [8]. Although a number of the epidemiological studies
have shown that exposure to passive tobacco smoke significantly
increases the risk of bacteremia and bacterial meningitis [9-11],
the pathogenic mechanisms of nicotine and tobacco smoke on this
disease are largely unknown. This receptor is abundantly
expressed in hippocampus, which is the region most vulnerable
to bacterial meningitis. A coordinated response has been
demonstrated between a7 nAChR and NMDA receptor
(NMDAR) [12]. Excitotoxic neuronal injury by the activity of
NMDAR has been implicated in the pathogenesis of bacterial
meningitis [13–14]. Opposite effects on neonatal excitotoxic brain
injuries could be induced by activation or suppression of a7
nAChR in the CNS when compared to that in adults [15],
suggesting that meningitic inflammation in neonates and adults
may be differentially regulated by nAChRs. On the other hand, a7
nAChR is a member of a family of ligand-gated ion channel,
having one of the highest permeabilities to calcium [16].
Cytoplasmic calcium signals are mediated by activation of
nAChRs through three different approaches: (a) direct calcium
influx through nAChRs, (b) indirect calcium influx through
voltage-dependent calcium channels, and (c) calcium-induced
calcium release from the endoplasmic reticulum [16]. Regulation
of intracellular calcium by a7 nAChR can lead to activation of
signal transduction pathways, including extracellular signal-
regulated kinase 1/2 (ERK1/2), cAMP response element binding
(CREB), and AKT [17]. It has been shown that nicotine was able
to activate Calcium/calmodulin-dependent kinase II (CaMKII) in
rat prefrontal cortex nerve terminals through a7 nAChR [18].
The prion protein (PrP
c) could bind to a7 nAChR to form a
signaling complex, which led to an increase in intracellular
calcium and activation of ERK1/2 [19].
Ca
2+ signaling has been found to be important in various steps
of microbial infection, including meningitis. Bacterial pathogens
and their products can induce an increase in intracellular Ca
2+ in
host cells [20]. Pneumolysin, a toxin of meningitic Pneumococcus,
was able to induce increases of intracellular Ca
2+ and trigger brain
cell apoptosis [21]. Meningitic E. coli was also able to increase
cytosolic-free-calcium levels of human BMEC in a manner
dependent on calmodulin [22], suggesting that calcium signaling
contributes to the pathogenesis of E. coli meningitis. Our recent
study demonstrated that IbeA (invasion of brain endothelium) + E.
coli invasion of HBMEC was positively correlated with phosphor-
ylation of the IbeA receptor vimentin at Ser82 by CaMKII and
pathogen-induced phosphorylation of ERK1/2 [23]. Interaction
between IbeA and vimentin at HBMEC membrane rafts is
essential for ERK1/2-mediated signalling, which modulate
meningitic E. coli K1 invasion. Erk1/2 activation is also required
for nicotine-enhanced E. coli K1 invasion of HBMEC in a manner
dependent on the recruitment of a7 nAChR and related signaling
molecules, including vimentin, and Erk1/2, to caveolin-1 enriched
lipid rafts [24]. It remains to be determined, however, whether and
how a7 nAChR-mediated calcium signaling contributes to
meningitic invasion in vitro and in vivo. Therefore, it is important
to further dissect its role in the pathogenesis of bacterial meningitis
and CNS injury by defining the mechanism by which it modulates
pathogen penetration across the BBB.
The migration of leukocytes across the BBB into the CNS is
critical in the pathogenesis of bacterial meningitis [25]. It is a key
aspect of the protective response against invading pathogens, but
in recent years, evidence has accumulated that leukocytes also
contribute importantly to the deleterious effects of inflammation
on the brain in bacterial meningitis [26]. The adhesive interactions
between transmigrating leukocytes and endothelial cells are well
understood. We have recently defined E. coli K1-induced adhesive
interactions between transmigrating leukocytes and brain endothe-
lial cells in a manner dependent on the IbeA receptor vimentin[27].
ICAM-1 and CD44 play a role in the leukocyte transmigration
process during E. coli meningitis. It has been demonstrated that
leukocytes are able to transmigrate across the endothelium by using
both paracellular and transcellular pathways. Recent studies show
that blood lymphocytes and neutrophils preferentially transmigrate
acrossperipheral and brain endothelial cells via a transcellular route
[28]. This notion is supported by our recent findings that
transcellular migration of PMN across HBMEC is induced by
meningitic E. coli K1 [27]. It has been shown that nicotine could
induce significant dose-related increases in leukocyte rolling and
adhesion in the cerebral microcirculation of the mouse brain [29].
Endothelial cell activation and leukocyte recruitment was regulated
through the a7 nAChR cholinergic pathway during endotoxin-
induced inflammation [30]. Currently, it is unclear whether and
how the a7 nAChR cholinergic pathway contributes to PMN
transmigration across the BBB during meningitic infection. As a7
nAChR is a key regulator of inflammation [3], it is important to
examine whether this receptor on both leukocytes and the
endothelium is essential for modulation of meningitic virulence
factor-induced PMN transmigration across the BBB.
In this report, using a7-deficient mouse cell culture and animal
model systems, we examined how a7 nAChR contributed to the
modulation of pathogen invasion, PMN recruitment and neuronal
inflammation induced by E. coli K1, which is the most common
gram-negative pathogen causing neonatal bacterial meningitis. The
in vitro and in vivo models permit genetic dissection of the role of a7
nAChR in modulation of host defense against meningitic pathogen
invasion. We also sought to examine whether the a7 receptor on
both BMEC and leukocytes is required for the recruitment of PMN
into the CNS, which is associated with increased permeability of the
BBB and neuronal injury. Finally, we assessed a7 nAChR-mediated
calcium signaling and proinflammatory factors that have the
potential to affect the outcome of bacterial meningitis.
Results
Isolation and characterization of mouse BMEC (MBMEC)
from wildtype and a7 knockout animals
In order to establish in vitro models for examining the role of a7
nAChR in E. coli invasion and PMN transmigration, wildtype (WT)
and a7 nAChR knockout (KO) MBMEC were isolated and purified
fromthebrainsof10-day-oldwildtype(a7
+/+)anda7-deficientmice
(a7
-/-) using UEAI lectin-coated beads as described in Methods and
Materials. Under the light microscope, the isolated cells showed
endothelialcelltypemorphologyinboth the WT and KOMBMEC
(Figure S1A). Then, the cells were stained with antibodies against
the mouse endothelial marker CD146 (FITC conjugate) and the
brain cell markers GGT (FITC) and S100B (FITC), respectively,
demonstrating that the cells were derived from brain microvascu-
lature (Figure S1A). The tight junction (TJ) formation was stained
with the TJ marker ZO-1 (FITC) (Figure S1A). Next, the deficiency
of a7 nAChR was confirmed by the absence of a-bungarotoxin (a-
BTX) binding sites in KO MBMEC (Figure S1A) and the KO
mousebraintissues(FigureS1C) usingthe rhodamineconjugated a-
BTX binding assay [31], and the lack of a7 nAChR in KO
MBMEC by immunnoblotting with a rabbit antibody against the
mousea7receptor(FigureS1B).Theseresultsconfirmed thatthea7
nAchR was completely deleted in MBMEC derived from the
knockout mice.
Role of Alpha7 nAchR in Pathogenesis of Meningitis
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To determine the role of a7 nAchR in the pathogenesis of E. coli
meningitis, we examined whether KO MBMEC treated with and
without nicotine were defective in bacterial invasion. To mimic the
concentrations of nicotine measured in the serum of human active and
passive smokers [32], MBMEC (a7
+/+) were exposed to low doses of
nicotine (0.1 to 10 mM) for 48 h or 10 mM of nicotine at different time
points (0–72 h). The results indicated that E. coli K1 invasion was
significantly enhanced by nicotine in a dose- and time-dependent
manner (Figure 1A-B). WT MBMEC were then incubated with or
without nicotine (10 mM) for 48 hours, and treated with the a7
antagonist methyllycaconitine (MLA). The result indicated that MLA
was able to block E. coli invasion of MBMEC treated with and without
nicotine in a dose-dependent manner (Figure 1C). The WT and KO
MBMEC treated with or without nicotine were then subjected to
bacterial invasion assays. The invasion rates of WT MBMEC were
much higher than that of KO MBMEC even without nicotine
stimulation, suggesting that a7 nAChR might play a regulatory role in
bacterial invasion in a manner independent of nicotine (Figure 1D).
Since nicotine could not increase the invasion rate in KO MBMEC
when compared to that in WT MBMEC, a7n A C h Rs h o u l db et h e
major receptor for nicotine-induced cellular effects. Taken together,
these studies suggest that a7 nAChR contributes to bacterial invasion
in a nicotine-dependent and independent manner.
a7 nAChR in BMEC and PMN is required for leukocyte
transmigration across MBMEC
PMN recruitment into the CNS plays a crucial role in the
inflammatory response during bacterial meningitis [25]. In order to
exclude the possibility that the leukocyte migration elicited was due
to destruction of MBMEC, the integrity of the monolayer was
inspected by microscopy. WT MBMEC were exposed to low doses
of nicotine (0.1 to 10 mM) for 48 h or 10 mM of nicotine at different
time points (0–72 h), and subjected to PMN transmigration assays.
As indicated in Figure 2A and 2B, nicotine significantly increased
PMN transmigration in a dose- and time-dependent manner. MLA
was able to significantly inhibit PMN transmigration across the
wildtype MBMECmonolayertreatedwithand withoutnicotineina
dose-dependent manner (Figure 2C). MLA-mediated blocking
effects were observed upon treatment of either cell type alone or
both (Figure 2D), suggesting that a7 nAChR expression on both
leukocytes and MBMEC is required for nicotine-enhanced PMN
transmigration in vitro. To further support this conclusion, a7
+/+ and
a7
-/- MBMEC and PMN were used in leukocyte adhesion and
migration assays. As shown in Figure 2E and 2F, both a7
-/-
MBMEC and a7
-/- PMN were significantly defective in leukocyte
adhesion and transmigration when compared to the wildtype cells.
These results were consisted with the result of chemical blockage by
MLA, suggesting that a7 nAChR on BMEC and PMN is required
for leukocyte adhesion and transmigration.
a7 knockout neonatal mice are defective in E. coli
K1-induced bacteremia, bacterial meningitis, PMN
recruitment and nicotine-mediated stimulation
To further validate the biological relevance of the in vitro assays,
the role of a7 nAChR in the pathogenesis of neonatal E. coli K1
meningitis was tested in the mouse model, as described in Methods
and Materials. We first examined the effects of the a7 antagonist
MLA on nicotine-enhanced meningitis in wildtype mice. In this
study, wildtype neonatal (10 day-old) mice were intraperitoneally
injected with E44 (2610
5 CFU) after treatment with nicotine or
MLA for 3 days. As shown in Figure 3, nicotine was able to
significantly increase E. coli bacteremia (P,0.01, Figure 3A),
bacterial entry into brain and CSF (meningitis) (P,0.01, Figure 3B
Figure 1. Effects of chemical and genetic blockages of a7 nAChR on E44 invasion in vitro. E44 invasion of WT MBMEC after exposure to
nicotine (NT) at different doses (0.1 to 10 mM) for 48 h (A) and 10 mM of NT at different points (0–72 h) (B). (C) Effects of different doses of MLA (1 h
incubation) on E44 invasion of WT MBMEC treated with (10 mM NT for 48h) and without NT. (D) Effect of genetic blockage of a7 on E44 invasion of
MBMEC with or without NT treatment (10 mM for 48h). In all treatments, the WT MBMEC without any treatment was taken as a control, and all results
are expressed as relative invasion compared the corresponding controls without treatments (100%). All invasion assays were performed in triplicate
wells. Bar graphs show the means 6 SD of triplicate samples. Significant differences with regard to the controls are marked by asterisks (*P,0.05;
**P,0.01).
doi:10.1371/journal.pone.0025016.g001
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Figure 3C). MLA was able to significantly block nicotine-enhanced
pathogenicities when compared to the controls. Theseresults suggest
that a7 nAChR could increase the host susceptibility to E. coli K1
meningitis. To further confirm this conclusion, the host susceptibility
to E. coli K1 meningitis was tested in wildtype and KO neonatal
mice. Animals of the same age were intraperitoneally injected with
E44 (2610
5 CFU), followed by Evans blue injection after 15h. As
shown in Figure 4A, bacteremia was significantly decreased in KO
mice as compared to wildtype animals (P,0.05), suggesting that a7
nAChR plays a role in the genesis of bacteremia. This result showed
that the magnitude of bacteremia was significantly increased by
nicotine exposure only in wildtype mice (P,0.01), but not in KO
mice, suggesting that a7 nAChR is essential for nicotine-enhanced
bacterial pathogenicities (Figure 4A). Similarly, the bacterial counts
in brain and CSF were significantly reduced in KO mice as
compared to wildtype animals (P,0.01), suggesting that a7n A C h R
also contributes to E. coli K1 penetration across the BBB (Figure 4B
and Figure S2B). E. coli K1 was also able to significantly increase
PMN transmigration across the BBB into CSF in wildtype mice as
compared to KO animals (P,0.01, Figure 4C). Nicotine was only
able to enhance PMN transmigration across the BBB in wildtype
mice as compared to corresponding controls (P,0.01), suggesting
thatleukocytetransmigrationacrosstheBBBismainlymodulatedby
a7 nAChR. Histologic examination of brains with hematoxylin-
eosin staining indicated that nicotine was able to significantly
enhance the recruitment of PMN into the CNS induced by E44 cells
in the wildtype mice but not in KO mice (Figure 4D), which further
confirmed the role of a7 nAChR in PMN transmigration across the
BBB. Taken together, these data suggested that a7 nAChR could
play a detrimental role in the host defense against E. coli meningitis
by increasing E. coli bacteremia, bacterial invasion, and PMN
transmigration across the BBB.
E. coli bacteremia and meningitis in heterozygous mice
To further examine whether a single allele was sufficient to
complement the role of a7 nAchR in the pathogenesis of E. coli
meningitis, the heterozygous (+/-) neonatal mice were also
subjected to i.p. injection of the same inoculum size of E44. The
wildtype and heterozygous animals did not show marked
differences in bacteremia (Figure S3A), bacterial counts in brain
tissues and CSF (Figure S3B and S3C), and the rate of PMN
transmigration across the BBB (Figure S3D). These results suggest
that a single allele could retain the full function of a7 nAChR to
increase host susceptibility to E. coli K1 meningitis.
Tobacco smoking increased E. coli K1-induced
bacteremia, bacterial meningitis, PMN recruitment into
the CNS of neonatal mice
Since nicotine is a major component in tobacco smoke, we
examined the effect of tobacco smoking on pathogenesis of
Figure 2. Effects of chemical and genetic blockages of a7 nAChR on NT-enhanced PMN transmigration across BBB. (A) E44-induced
PMN transmigration across WT MBMEC that were exposed to different doses of NT (0.1 to 10 mM) for 48 h. (B) E44-induced PMN transmigration across
WT MBMEC that were exposed to NT (10 mM) for 0-72h. (C) Effects of different doses of MLA (1 h incubation) PMN transmigration across WT MBMEC
treated with (10 mM NT for 48h) and without NT. (D) Effect of MLA treatment of either MBMEC or PMN on NT-enhanced PMN transmigration. WT
MBMEC were pre-exposed to 10 mM NT for 48 h, and then MBMEC and PMN were treated with MLA for 1 hr prior to the leukocyte transmigration
assay. The a7 deficiency of either MBMEC or PMN resulted in a significant suppression of E44-induced PMN binding (E) and transmigration (F) with or
without NT exposure. WT and KO MBMEC were exposed to 10 mM NT for 48 h before the PMN adhesion and transmigration assays. For the PMN
adhesion assay, results were expressed as relative adhesion compared to the WT cells (PMN and MBMEC) (100%). Values represent the means of
fifteen randomly selected fields from triplicate wells as described in Methods and Materials. For the PMN transmigration assay, values represent the
means of % transmigrating PMN of triplicate samples. Bar graphs show the means 6 SD of triplicate samples. In (D), the experimental setting without
MLA treatment was taken as a control (the first column). In (E) and (F), the WT cells (PMN and MBMEC) without any treatment served as controls. Bar
graphs showed the means 6 SD of the triplicate samples. *P,0.05, **P,0.01.
doi:10.1371/journal.pone.0025016.g002
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was performed from postnatal day 4 to day 10 with wildtype
neonatal mice as described in Methods and Materials. At day 10,
the neonatal mice with or without tobacco smoking were
intraperitoneally injected with E44 (2610
5 CFU). As shown in
Figure S4, tobacco smoking was able to significantly increase E.
coli bacteremia (P,0.01, S Figure S4A), bacterial entry into brain
tissues and CSF (meningitis) (P,0.01, Figure S4B and S4C), and
Figure 3. MLA-mediated inhibition of bacteremia, bacterial entry into the brain, and PMN transmigration across BBB. (A) Magnitude
of bacteremia in WT mice treated with NT or MLA. (B) Bacterial loads in the brains of WT mice treated with NT or MLA. (C) Migration of PMN into the
CSF of WT mice treated with NT or MLA. WT neonatal mice were divided into 4 groups (6–8 pups/group). Each experiment was repeated three times.
*P,0.05, **P,0.01.
doi:10.1371/journal.pone.0025016.g003
Figure 4. Effects of a7 deficiency on bacteremia, bacterial entry into brain, and PMN transmigration across BBB. (A) Magnitude of
bacteremia in WT and KO mice treated with or without NT. (B) Bacterial loads in the brains of WT and KO mice treated with or without NT. (C)
Migration of PMN into the CSF of WT and KO mice treated with or without NT. WT and KO neonatal mice were divided into 4 groups (6–8 pups/
group). Each experiment was performed three times. *P,0.05, **P,0.01. (D) The recruitment of PMN into the CNS of WT and KO mice treated with
NT and infected with E44. Brain cortex sections were stained with hematoxylin-eosin. Arrows indicate infiltrating PMN. Images are 2006.
doi:10.1371/journal.pone.0025016.g004
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data suggested that second hand tobacco smoking could be a
significant risk factor for E. coli meningitis in neonates.
a7 deficient BMEC and animals are defective in E. coli
K1- and nicotine-induced BBB disorders
As pathogen penetration and PMN transmigration across the
BBB are the most critical step in the pathogenesis of bacterial
meningitis [1-2], we tested whether the BBB permeability was
increased by a7 nAChR. BBB permeability was first examined in a
Transwell system with wildtype and KO MBMEC treated with
nicotine or E44 cells. As shown in Figure 5A, the passage of
horseradish peroxidase (HRP) through wildtype MBMEC mono-
layers was increased upon infection with E44 cells in a time-
dependent manner. The E44-mediated stimulation was amplified
by exposure to nicotine in the same manner. These results
demonstrated that nicotine could enhance the BBB permeability in
vitro. Nicotine exposure was unable to increase the E44-induced
BBB permeability in KO MBMEC as compared to the negative
control without nicotine treatment, suggesting that a7 nAChR
contributes to increased BBB permeability induced by both E. coli
K1 and nicotine. E. coli K1 translocation across the MBMEC
monolayer in the two chamber transwell system was also examined
by plating bacteria at different time points (Figure 5B). The result
indicated nicotine treatment could accelerate E. coli K1 translo-
cation across WT MBMEC, while the a7 nAChR deficiency led to
decreases in E. coli K1 translocation. These in vitro results were
consisted with the conclusion drawn from the in vivo studies using
the mouse model of neonatal E. coli meningitis. Quantitative
evaluation of the BBB damage was performed using the Evans
blue (EB) extravasation assay. As shown in Figure 5C, nicotine was
able to more significantly increase E44-induced permeability of the
BBB in wildtype mice (P,0.01) when compared to that in KO
animals (P,0.05). The enhanced permeability of the BBB induced
by E44 cells was significantly increased in wildtype mice as
compared to KO mice. These results suggest that a7 nAChR is
required for pathogen- and nicotine-increased BBB permeability.
As shown in images of mouse brains with EB staining (Figure 5D),
substantially heavier EB staining was seen in wildtype animals
treated with nicotine than in other treatment settings. Alterna-
tively, the permeability of the BBB was examined by measuring
albumin in CSF samples, as described previously [33]. Nicotine-
enhanced albumin passage across the BBB was reduced by either
chemical (MLA) (Figure S2C) or genetic (KO) (Figure S2D)
blockage of a7 nAChR. Accordingly, albumin passages across the
BBB were also increased in nicotine-treated heterozygous mice
(Figure S3E) and the WT mice with tobacco smoking (Figure S4E).
Figure 5. Effects of genetic blockage of a7 nAChR on NT-increased BBB permeability and E44 transcytosis. (A) Time-course study of
BBB permeability to HRP in WT and KO MBMEC with or without NT (10 mM) exposure for 48 hours. (B) Time-course examination of E. coli K1
penetration across WT and KO MBMEC treated with or without NT (10 mM). In both (A) and (B), values represent the means of triplicate samples from
lower chambers. (C) Evaluation of BBB permeability to Evans blue in WT and KO mice with or without NT exposure (n=6-8). *P,0.05, **P,0.01. (D)
Images of mouse brains stained with Evans blue.
doi:10.1371/journal.pone.0025016.g005
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uted to modulation of the BBB permeability.
Effects of a7 deficiency on E. coli K1- and
nicotine-induced impairment of tight junction
To compare the integrity of the BBB in vitro and in vivo upon
stimulation with nicotine and E44, the tight junction molecules
occludin and ZO-1 were examined by immunoblotting and
immunohistochemical staining. Immunoblotting indicated that
nicotine could decrease the expressions of ZO-1 and occludin in a
dose- (0.1–10 mM) and time-dependent (0–72 h) manner in WT
MBMEC, while expression of a7 nAChR was increased in a dose-
and time-dependent fashion during the treatments (Figure S5A and
S5B). It concurred with a previous report that nicotine could
upregulate a7 nAChR through activation of nuclear transcription
factor kappa B [34]. Chemical blockage of a7 nAChR by MLA
could reverse the effects of nicotine on ZO-1 and occludin
expressions in a dose-dependent manner, while the up-regulated
expressions of a7 nAChR by nicotine were reduced to the basal level
(Figure S5C). Then, WT and KO MBMEC were treated with
nicotine and E44 alone or in a combination. A greater decrease in
expression of ZO-1 and occludin was observed in the combination
settings than either treatment alone in WT MBMEC (Figure 6A).
However, these effects were significantly reduced in KO MBMEC,
suggesting that the a7 deficiency could protect the tight junction
from nicotine- and bacteria-induced degradation. Immunohisto-
chemical staining of occludin and ZO-1 in mouse brain cortex were
consistent with the invitro data.Asshown inFigure 6C, E44 infection
significantly reduced occludin expression in the cortex. A combined
treatmentwith nicotineand E44 resultedinanadditiveorsynergistic
effect of decreased occludin expression in the brain tissues, which
was much lower than that in other treatment settings in the wildtype
mice. These results showed that both E. coli K1 and nicotine could
induce BBB damage by decreasing expression of tight junction
molecules. However, E44 and nicotine only induced slight changes
in occludin expression in the brains of KO mice, suggesting that a7
nAChR is required for E44- and nicotine-induced BBB damages.
The quantification analysis of occludin fluorescence intensity was
showed in Figure 6B, confirming the detrimental role of a7n A C h R
to BBB. Similar results were obtained when examining ZO-1
expression (Figure S5D and S5E). These results suggest that a7
nAChR contributes to pathogen- and nicotine-increased BBB
permeability by decreasing protein levels of tight junction molecules.
Neuronal injury in the hippocampus is reduced in a7
-/-
mice with E. coli meningitis
Bacterialmeningitiscausesneuronaldamagethatpredominatesin
the hippocampal dentate gyrus [35]. In light of this, we next
examined the neuronal injury in the hippocampus in the murine
model of E. coli meningitis using the TUNEL assay for detecting
Figure 6. Effects of a7 knockout on nicotine- and E44-induced disruption of tight junction (TJ). (A) Immunoblotting showed the
expression of tight junction molecules occludin and ZO-1 in WT and KO MBMEC upon treatment with nicotine (10 mM for 48 h) and E44 (10
6/ml for
4h) alone or in combination. b-actin was used as an internal loading control. (B) Quantification of occludin expression in WT and KO mouse (n=5-6)
brain cortex upon treatment with or without NT and E44. The fluorescence intensities of occludin were quantified and expressed as relative
expression compared to the controls. The control (WT) without any treatment was taken as 100%. (C) Immunostaining of TJ molecules in mouse brain
cortex with or without NT exposure and E44 infection using antibodies against occludin (rhodamine-conjugated). A FITC-conjugated anti-CD146 Ab
was used to stain MBMEC, and DAPI was used to stain the structures of brain cortex in the merged pictures. CON: mice without any treatment. E44:
mice infected with E44. NT+E44: NT-treated mice infected with E44. Images are 2006.
doi:10.1371/journal.pone.0025016.g006
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neurons. As shown in Figure 7A and 7B, no or few TUNEL-positive
neurons were found in the dentate gyrus of the hippocampus within
untreated wildtype and KO mouse brains. E. coli infection
significantly induced TUNEL-positivity in neurons of the inner
layers of dentate gyrus in wildtype mouse brains, but not in KO
mouse brains. Nicotine dramatically enhanced E. coli virulence as
measured by the induction of neuronal apoptosis in wildtype mouse
brains; however, only a few apoptotic neurons were found in KO
mousebrainsascompared to the control.Thequantificationanalysis
of TUNEL staining fluorescence intensity was shown in Figure 7C,
confirming the detrimental role of a7 nAChR in neuronal injury.
These data demonstrated that the deficiency of a7 nAChR was
neuroprotective for neonatal mice with E. coli meningitis.
Cerebrospinal fluid (CSF) cytokine levels are reduced by
chemical (MLA) and genetic (a7 KO) blockage of a7
nAChR during E. coli K1 meningitis
To further determine the role of a7 nAChR in the CNS
inflammation, the levels of cytokines in CSF samples were
measured using the Cytometric Beads Array (CBA) assay as
described in Methods and Materials. This technique is able to
quantify multiple proteins simultaneously with the use of the broad
dynamic range of fluorescence detection offered by flow cytometry
and antibody-coated beads to efficiently capture analytes. The
levels of cytokines in CSF, including IL-1b, IL-6, TNFa, MCP-1,
MIP-1a and RANTES were analyzed (Figure 8A-F). The data
showed that nicotine could significantly increase the levels of all of
these cytokines except MIP-1a, while the deficiency of a7 nAChR
resulted in a significant decrease of these cytokines. Nicotine was
unable to significantly upregulate these cytokines in KO mice.
Meningitic Cryptococcus neoformans was unable to up-regulate
expression of cytokines under the similar experimental settings
(data not shown), suggesting that induction of pro-inflammatory
factors is pathogen-dependent. In addition, the a7 antagonist
MLA could inhibit these cytokines in nicotine-treated mice. These
data suggested that a7 nAChR could upregulate inflammatory
cytokines in E. coli K1 meningitis.
E. coli K1- and nicotine-increased protein levels of
adhesion molecules ICAM-1 and CD44 were reduced in
a7-deficient cells and animals
A so u rp r e v i o u ss t u d yh a ss h o w nt h a tE. coli K1-increased
expression ofadhesion molecules ICAM-1(CD54)and CD44(HCAM)
Figure 7. Reduced neuronal injury in the hippocampus of a7 KO mice. (A) Neuron damage in the dentate gyrus of hippocampus within WT
and KO mouse brains was examined by the TUNEL assay. Neurons were stained with an antibody against neuron nuclear protein (NeuN) (FITC-
conjugated). Apoptotic cells were stained with rhodamine after the TUNEL assay. CON: mice without any treatment. E44: mice infected with E. coli K1.
NT+E44: NT-treated mice infected with E44. Images are 1006. The squared areas in merged pictures were enlarged in (B) to show the details of
TUNEL staining. Images are 2006.( C) Quantification of TUNEL-staining in the dentate gyrus of hippocampus within WT and KO mice (n=5-6) treated
with or without NT and E44. The fluorescence intensity of TUNEL staining was quantified with the dentate gyrus of hippocampus and expressed as
relative expression compared to the controls. The control (WT) without any treatment was taken as one fold.
doi:10.1371/journal.pone.0025016.g007
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we examined their expression in a7
-/- cells and mice. As shown in
Figure 9A and B, both nicotine and E44 could increase the
expression of ICAM-1 and CD44 in a7
+/+ MBMEC, and the
expression was dramatically up-regulated with combination of
nicotine and E44. However, there were no significant changes in
expressions of ICAM-1 and CD44 in a7
-/- MBMEC, suggesting
that a7 nAChR is required for both nicotine- and E. coli K1-
induced expression of the analyzed adhesion molecules. To
validate the relevance of the in vitro results, CSF samples taken
from neonatal mice with meningitis (positive bacterial cultures in
brain tissues) were used to examine the levels of soluble ICAM-1
and CD44. Results were consistent with the in vitro findings, which
showed that E44 infection could increase the expression of ICAM-
1 and CD44 in wildtype mice, and that nicotine could amplify
E44-induced expression of these two adhesion molecules in the
wildtype animals (Figure 9C and D). However, there is little
difference in their expression levels in KO mice treated with either
E44 or a combination of E44 and nicotine. In addition,
accumulation of soluble CD44 in the CSF was significantly
reduced in KO mice compared with wildtype animals after E. coli
infection, suggesting that a7 nAChR contributes to up-regulation
of adhesion molecules induced by both nicotine and E. coli K1.
a7 nAChR-mediated calcium signaling contributed to E.
coli K1-induced bacterial invasion and PMN
transmigration
Calcium signaling has been found to be important for the
pathogenesis of bacterial infection [20] and the biological
functions of a7 nAChR [18]. The E. coli K1 virulence factor is
able to increase intracellular transient calcium flux in human
BMEC [22], but the underlying mechanism is unknown. Based on
the above findings and the relatively high calcium permeability of
the a7 nAChR ion channel, we hypothesized that a7 nAChR-
mediated calcium signaling might be the major regulatory
pathway for the CNS inflammatory response to bacteria and
other pathogenic insults, including nicotine. To test this hypoth-
esis, we examined the role of a7 nAChR in E44- and nicotine-
induced signaling using wildtype and KO MBMEC. Fura-2 AM, a
calcium fluorescence dye, was used for measurement of intracel-
lular free calcium. Changes in the ratio of 340 nm/380 nm were
calculated as representing the strength of calcium flux. The ratio
changes occurred immediately in wildtype MBMEC upon E44
stimulation with a range of 0.5-3 fold increase (Figure 10A). Much
higher ratio changes (3-10 fold) were observed in the same cells
stimulated with E44 after exposure to nicotine for 48 hours
(Figure 10B). These results indicated that nicotine could amplify
the transient intracellular calcium flux induced by E44, which
might be the initial step of bacterial invasion. However, KO
MBMEC did not exhibit significant ratio changes upon stimula-
tion with E44 (Figure 10C), suggesting that a7 nAChR might be
the major pathway for the E. coli K1-induced calcium flux. KO
MBMEC exhibited much lower fold increase in ratio changes than
in wildtype cells under the same treatment settings (E44 plus
nicotine) (Figure 10D). These results showed that the deficiency of
a7 nAChR significantly reduced the intracellular calcium flux
upon stimulation with nicotine and E44. However, KO MBMEC
showed a slight increase in the ratio upon co-stimulation with
nicotine and E44 as compared to the same cells without nicotine
Figure 8. Decreased CSF cytokine levels in a7 KO mice. Inflammatory cytokine levels in mouse CSF after E. coli infection were examined by the
Cytometric Beads Array (CBA) as described in Methods and Materials. The values were expressed as concentrations of cytokines (pg/ml or ng/ml)
representing means of 4-5 samples for each group. WT mice served as the control (*P,0.05; **P,0.01).
doi:10.1371/journal.pone.0025016.g008
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interact with nicotine. To further confirm the role of a7 nAChR in
nicotine- and E44-induced calcium signaling, MLA-mediated
chemical blocking was also tested. The result showed that MLA
could completely abolish the E. coli K1-induced calcium flux in
wildtype MBMEC without nicotine treatment (Figure 10E), and
significantly reduce the ratio changes in wildtype MBMEC
exposed to nicotine (0-2 fold, Figure 10F), suggesting that E. coli
K1-induced calcium flux was entirely dependent on a7 nAChR.
Statistical analysis indicated that either chemical (MLA) or genetic
(KO) blockage of a7 nAChR could significantly inhibit E44-
induced intracellular calcium flux in MBMEC with or without
nicotine exposure (Figure 10G). These results were consisted with
the conclusion drawn from the studies with KO MBMEC. To
further confirm this conclusion, inhibitors of the calcium signaling
pathway, including inhibitors of calmodulin [trifluoperazine
(TFP)] and calmodulin kinase II (KN93), and the calcium
chelating agent EGTA, were tested for their ability to block
bacterial invasion and PMN transmigration. As shown in
Figure 10H and 10I, these inhibitors could significantly block E.
coli K1 invasion and PMN transmigration in wildtype MBMEC
with or without nicotine exposure. These data suggest that a7
nAChR-mediated calcium signaling contributes to nicotine-
mediated stimulation, E. coli K1 invasion and PMN transmigration
across the BBB.
Discussion
Currently, the mechanisms responsible for the modulation of
the host response to microbial infection are incompletely
understood, but overwhelming evidence suggests that there are
active connections between the nervous, endocrine, and immune
systems during the regulation of inflammatory processes in various
types of cells and tissues [4,36]. The cholinergic a7 nAChR
pathway has recently been found to play an essential role in
regulation of host inflammatory response to microbial infection [3-
4,8]. Since the activation of the a7 receptor, the major subtype of
neuronal nAChRs, has deleterious effects on neonatal brain
injuries [15], an understanding of the early inflammatory response
to meningitic infection is important for the prevention and
treatment of neonatal bacterial meningitis. We were interested,
therefore, in dissecting the regulatory role of a7 nAChR in the
host defense against meningitic infection. In this report, we have
established that a7 nAChR plays a detrimental role in host defense
Figure 9. Decreased expression of ICAM-1 and CD44 in a7
-/- MBMEC and mice. (A) and (B) Expression analysis of cell surface ICAM-1 and
CD44 in a7
-/- MBMEC upon treatment with NT and E. coli K1. WT and KO MEBMC were cultured in 96-well plates, exposed to NT (10 mM) for 48 hours,
and incubated with E44 cells (10
6/ml) for 4 hours. Cells were fixed and subjected to ELISA for ICAM-1 and CD44 as described in Methods and
Materials. WT MBMEC without any treatment was taken as a control and set as one fold. (C) and (D) Decreased levels of soluble ICAM-1 and CD44 in
KO mouse CSF. WT and KO mouse CSF samples were subjected to ELISA assays for the expression of ICAM-1 and CD44 as described in Methods and
Materials. Values were expressed as relative expression. WT mice without any treatment severed as controls, and their means were defined as one-
fold. (*P,0.05; **P,0.01).
doi:10.1371/journal.pone.0025016.g009
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pathogens and leukocytes into the CNS, which is correlated with
increased BBB permeability, is significantly reduced in the a7-
deficient mice. Calcium signaling mediated by a7 nAChR is the
major regulatory pathway for the CNS inflammatory response to
meningitic E. coli infection and nicotine exposure. The resulting
neuronal inflammation, including secretion of proinflammatory
factors (IL-1b, IL-6, TNFa, MCP-1, MIP-1a, RANTES, CD44
and ICAM-1) into the CSF and inflammatory response in the
hippocampus, is significantly reduced in a7-deficient mice during
E. coli meningitis. Furthermore, these findings are consistent with
clinical observations in humans of an increased incidence of
bacterial meningitis as a consequence of exposure to second hand
tobacco smoke containing nicotine, an a7 agonist that enhances
a7 nAChR activation. These findings provide insight into an
element of host defense previously unknown to influence the
susceptibility to bacterial meningitis, and present novel opportu-
nities to improve disease outcome in humans.
The cholinergic a7 nAChR pathway-mediated inflammatory
regulation has been extensively investigated in models of
experimental sepsis, endotoxemia, ischemia/reperfusion injury,
hemorrhagic shock, arthritis, and other sterile inflammatory
disorders [37]. However, studies on its role in the innate immune
response to microbial infection are very limited. These include a
few in vitro studies on bacterial infection involving chemical
stimulation and blockage of the cholinergic pathways [8,38], and a
recent investigation on bacterial peritonitis by genetic blockage of
a7 nAChR [4]. In order to determine whether and how a7
nAChR plays a role in the pathogenesis of bacterial meningitis, we
first established the in vitro and in vivo mouse models of the BBB
Figure 10. Involvement of a7 nAChR in E. coli K1-induced intracellular calcium flux. (A–F) Elevation of intracellular calcium flux in MBMEC
stimulated with E44 cells. WT and KO MBMEC monolayers were exposed to NT (10 mM) or MLA (1 mM) for 48 hours, and then loaded with Fura-2 AM
as described in Methods and Material. The monolayer was monitored for intracellular calcium flux for 10 minutes with 4 s intervals under an
automated fluorescent microscope. Monolayer cells were stimulated with E44 cells (10
8 CFU) at the 120 s time point. The intensity of fluorescence at
340 nm and 380 nm was measured. The ratios of intensity of fluorescence at 340 nm and 380 nm were calculated for each time interval and depicted
as continuous lines in (A–F). The y axis represents the ratio, and x axis represents time (s). For each treatment, measurements were repeated with
nine replicates and represented with different colors. (G) The 340 nm/380 nm ratio changes in each treatment were calculated and subjected to
statistical analysis. WT MBMEC without any pre-treatment served as a control and defined as one-fold (1.0). (H) and (I) NT-enhanced E44 invasion and
PMN transmigration in WT MBMEC was blocked by inhibitors of calcium signaling, TFP, KN93, and EGTA. MBMEC were pre-incubated with or without
NT (10 mM) for 48 hours, and then treated with TFP (5 mM), KN93 (25 mM) and EGTA (100 mM) for 1 hour before the invasion or PMN transmigration
assays. For the invasion assays, results are expressed as relative invasion compared to the positive control without any treatment (100%). All invasion
assays were performed in triplicate wells. For the PMN transmigration assays, values represent the means of transmigrating PMN (%) in triplicate
samples. Bar graphs showed the means 6 SD of triplicate samples. In both invasion and PMN transmigration assays, significant differences with
regard to the controls (MBMEC without any treatment) were marked by asterisks (*P,0.05; **P,0.01).
doi:10.1371/journal.pone.0025016.g010
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genetic approaches for inhibition and stimulation of the cholin-
ergic a7 nAChR pathway. The combined approaches could
maximize their advantages and minimize their disadvantages.
Both E. coli K1 invasion and PMN transmigration were
significantly reduced in a7
-/- MBMEC and a7
-/- mice when
compared to that in the wildtype cells and animals. The a7K O
cells and mice were unable to generate a response to a7 agonist
(nicotine)-mediated stimulation during bacterial infection. The a7
antagonist MLA was able to block nicotine-mediated stimulation
in WT mice upon infection with E. coli K1. These findings suggest
that a7 nAChR plays an essential role in regulation of the host
inflammatory response to meningitic E. coli K1 infection. Thus,
the present report is the first to use a7
-/- cells and mice to dissect
the role of the cholinergic a7 nAChR pathway in host defense
against meningitic infection.
The most critical step in the pathogenesis of bacterial meningitis
is the penetration of the extracellular pathogens across the BBB, a
formidable defense system that normally keeps out pathogens and
toxins. It has been demonstrated that nicotine is able to modulate
the BBB permeability through the cholinergic a7 nAChR pathway
[39]. We and others have demonstrated that multiple bacterial
virulence factors, including Ibe proteins (IbeA, IbeB, IbeC and
IbeT), AslA (arylsulfatase-like gene), FimH (type 1 fimbrial tip
adhesin), TraJ (positive regulator of the F plasmid transfer (tra)
operon) and OmpA (outer membrane protein A) are able to
breach the BBB [27]. The precise mechanism responsible for the
E. coli K1-mediated increase in BBB permeability during
meningitis is largely unknown. Although it is well-known that
proinflammatory factors promote increased BBB permeability, it is
unclear how the production of these factors is regulated during this
disease. In this investigation, our results show that a7 nAChR is
able to directly or indirectly upregulate proinflammatory factors
and has a detrimental effect on the permeability of the BBB in the
early stages of meningitic infection. It is most likely that the a7
receptor-upregulated production of proinflammatory factors
results in increased BBB permeability, which facilitates the
entrance of pathogens and leukocytes into the CNS. This notion
is further supported by our finding that the a7 KO mice with
direct inoculation of E. coli K1 into the CSF show reduced
bacteremia and CNS inflammatory response (e.g., decreased PMN
recruitment and albumin leakage into CSF) when compared to
that in the wildtype animals (data not shown). This suggests that
accelerated bacterial clearance in a7 KO mice occurs.
The observation that a7-deficient BMEC were unable to
increase intracellular calcium concentrations upon stimulation
with either pathogens or the a7 agonist nicotine provides two key
pieces of information that are critical for elucidating the molecular
mechanism behind the a7 receptor-mediated suppression of the
host defense against bacterial meningitis. First, Ca
2+ signaling has
been implicated in meningitic E. coli K1 infection [22]. FimH,
which is regulated by IbeA [40], can induce an increase in free
cytosolic calcium in human BMEC. Phosphorylation of the IbeA
receptor vimentin by Ca
2+/CaMKII and activation of ERK1/2
are required for IbeA+ E. coli K1 invasion of human BMEC [23].
The current investigation demonstrated that nicotine and E. coli
K1 could additively or synergistically increase intracellular Ca
2+
concentrations through the cholinergic a7 nAChR pathway.
Pathogen-induced calcium fluxes in MBMEC were almost
completely abolished by either chemical (a7 antagonist MLA) or
genetic (KO cells) blockage. On the other hand, the nAChRs are a
family of ligand-gated calcium channels formed by a pentameric
complex of nAChR subunits [3]. Since the a7 receptor is the
major subtype of nAChRs in the CNS, it plays an important role
in calcium signaling in neuronal and non-neuronal cells through
regulation of intracellular calcium, which leads to activation of
signal transduction pathways, including ERK1/2, CREB, and
AKT [17]. Nicotine is able to activate the Ca
2+/calmodulin
signaling pathway through the a7 receptor [18]. Ca
2+/CaMKII
can be activated by galantamine, a novel Alzheimer’s drug, which
is known to inhibit acetylcholinesterase activity and potentiate
nicotinic acetylcholine receptor (nAChR) in the brain [41]. Our
results demonstrate that KN93, a specific inhibitor of Ca
2+/
CaMKII, is able to block nicotine-enhanced E. coli K1 penetration
across BMEC [23]. These findings suggest that the Ca
2+/
calmodulin signaling pathway is commonly activated upon
meningitic infection with pathogens and stimulation of the a7
receptor. Thus, meningitic pathogens and nicotine can additively
or synergistically induce the cellular release of Ca
2+ that may
expand bacterial cell signaling through the cholinergic a7 nAChR
pathway, leading to enhanced bacterial invasion and leukocyte
transmigration that are associated with the BBB disorders, and
increased host susceptibility to the invading microorganism.
However, the underlying molecular mechanisms that activate a7
nAChR-mediated calcium signaling and the exact nature of where
these signaling molecules are assembled and regulated remain
elusive. Research from several groups has demonstrated that lipid
rafts/caveolae can serve as microdomains of calcium signaling
through clustering of Ca
2+ channels and their regulators in such
platforms [42]. We have recently shown that E. coli K1 and
nicotine could increase the recruitment of a7 nAChR and related
signaling molecules, including vimentin, and Erk1/2, to caveolin-1
enriched lipid rafts [24]. Synergistic effects were observed upon
treatment with a combination of E. coli K1 and nicotine. These
findings suggest that lipid rafts/caveolae could provide a favorable
platform for cross-talk between the cholinergic signaling pathway
(e.g., a7 nAChR/CaMKII/ERK1/2) and non-cholinergic signal-
ing pathways (e.g., vimentin/CaMKII/ERK1/2).
It is worth noting that there may be a difference between
neonatal and non-neonatal patients regarding the role of a7
nAChR in neuronal injury during bacterial meningitis. It has been
reported that activation or suppression of a7 nAChR in the CNS
has opposite effects on neonatal excitotoxic brain injuries when
compared to that in adults [15]. Activation of a7 is protective in
adult animals but deleterious in neonatal mice, whereas its
blockade, either pharmacologically (a7 antagonist) or genetically
(a7
-/- mice), provides neuroprotection. However, it has been
shown that there is no difference between neonates and adults in
the deformability and volumes of leukocytes, which are essential
for PMNs emigration from the intravascular to the extravascular
space [43]. This suggests that a7 nAChR may differentially
contribute to modulation of the host inflammatory responses in
different tissues to different disease conditions. In the sterile
inflammatory disorder model used by Wang et. al. [3], a7 nAChR
plays an anti-inflammatory role in the host response against
endotoxin. However, this receptor contributes oppositely to the
host response to bacterial infections, including E. coli peritonitis [4]
and E. coli meningitis (this report). E. coli meningitis commonly
occurs in the neonatal period [1,2], but the basis of this age
dependency is largely unclear. The a7 nAChR cholinergic
pathway may be differentially regulated in an age-dependent
manner. Although a7 nAChR plays a major role in the cholinergic
anti-inflammatory pathway, the other major subtype of nAChRs
in the CNS, a4b2, partially mediate the anti-inflammatory
response, which is not dependent on calcium signaling [44],
suggesting that multi-subtypes of nAChRs may contribute to the
cholinergic regulation of inflammatory response in an elegant
manner. Nicotine, which can interact with the two major nAChRs
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levels of proinflammatory factors (IL-1b, IL-6, TNFa, MCP-1,
MIP-1a, RANTES) in CSF. The wildtype mice treated with
nicotine and MLA (a7 antagonist) had decreased responses
relative to the animals left untreated or treated with MLA alone,
suggesting that multi-subtypes of nAChRs may contribute to the
cholinergic regulation of proinflammatory responses. MLA may
be capable of antagonizing endogenous a7 agonists such as
acetylcholine and choline or competing with endogenous a7
inhibitors such as catestatin [36]. Considering the possible
involvement of multi-subtypes of nAChRs in meningitic infection
and the opposite effects of a7 nAChR activation/suppression on
neonatal excitotoxic brain injuries in neonates and adults, close
attention must be paid to the pathogenesis and therapeutic
manipulations of neonatal and non-neonatal bacterial meningitis.
Collectively, the major finding of the present report is that a7
nAChR deficiency is protective against meningitic infection by
down-regulation of pathogen invasion, PMN recruitment, calcium
signaling and neuronal inflammation. Further insight into how
meningitic pathogens utilize the host cholinergic a7 nAChR
pathway to augment their virulence capacity will advance our
understanding of the pathogenesis and therapeutics of bacterial
meningitis.
Methods and Materials
Ethics statement
This study was performed in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. Our
protocols were approved by the Institutional Animal Care and Use
Committee (IACUC) of The Saban Research Institute of
Children’s Hospital Los Angeles (Permit number: A3276-01). All
surgery was performed under anesthesia with ketamine and
lidocaine, and all efforts were made to minimize suffering.
Chemicals and reagent. Dextran, Evans blue, nicotine
tartrate (NT), MLA, TFP, and ethylene glycol tetraacetic acid
(EGTA) were purchased from Sigma-Aldrich (St. Louis, MO).
Dynabeads M-450 Tosylactivated, a–bungarotoxin (a–BTX)
tetramethylrhodamine conjugate, Fura-2 AM, Pluronic-127 were
purchased from Invitrogen (Carlsbad, CA). Ulex europaeus I
(UEA I) lectin and mounting medium with DAPI were purchased
from Vector (Buringame, CA). KN93 was purchased from
ALEXIS Biochemicals (San Diego, CA). All primary antibodies
(Ab) were purchased from the commercial sources: a rabbit anti-
ZO-1 Ab (33-1500) and a mouse anti-occludin Ab (61-7300) from
Invitrogen; a rabbit anti-a7 nAChR Ab from Genescript
(Piscataway, NJ); a rat anti-mouse Ly-6G (Gr-1) Ab, a mouse
anti-neuron (NeuN) Ab from eBiosciences (San Diego, CA); a
mouse anti-CD44 Ab (sc-7297), a rabbit anti-b-actin (sc-7210),
and a rabbit anti-GGT Ab (sc-20638) from Santa Cruz
Biotechnology (Santa Cruz, CA); an anti-mouse CD146 Ab
FITC-conjugated from Biolegend (San Diego, CA), a rabbit anti-
S100B Ab from BD Biosciences, and a rabbit anti-CD54 Ab
(ICAM-1, 250593) from Abbiotec (San Diego, CA). The TUNEL
assay kit was purchased from Millipore (Chemicon, Billerica, MA).
Transwell filters (3 mm pore size, 6.5 mm diameter), blood plates
and CBA assay kit were purchased from BD Biosciences (San Jose,
CA).
Mice. Heterozygous (+/2) a7-deficient mice with the
C57BL/6J background (B6.129S7-Chrna7
tm1Bay/J) were pur-
chased from Jackson Laboratory (Bar Harbor, ME). Genotypes
of a7
+/+ mice (WT mice), a7
-/- mice (KO mice) and heterozygous
a7
+/- mice were determined according to the PCR protocol
provided by the vendor. The animals were used in transgenic
breeding at 8 weeks of age for optimum reproductive
performance. Male heterozygous (+/2) and female homozygous
(-/-) were used in breeding. The average litter size for neonatal
mice was 6–8. Age- and sex-matched mice were used in all
experiments. All experiments were approved by the Animal Care
and Use Committee of Childrens Hospital Los Angeles Saban
Research Institute.
Isolation and purification of mouse brain microvascular
endothelial cells
Isolation of mouse BMEC was performed with Ulex europaeus I
(UEA I) lectin-coated Dynabeads as described previously [45].
The beads were prepared according to the manufacturer’s
instructions (Invitrogen) and resuspended in Hanks’ balanced salt
solution (HBSS, Invitrogen Corp., Carlsbad, CA, USA) plus 5%
fetal calf serum (HBSS+5 %FCS) to a final concentration of 46l0
8
beads/ml. The MBMEC were prepared as described previously
[46–47]. Briefly, the mouse (10-day-old) brain specimens devoid of
large blood vessels were homogenized in HBSS and centrifuged in
12.5 % dextran (Mr,70,000, Sigma) at 8,000 g for 10 min. Pellets
containing crude microvessels were further digested in a solution
containing collagenase (0.1 U/ml), dispase (0.8 U/ml) and DNase
I (10 U/ml, Sigma). Microvascular capillaries were isolated by
absorption to Ulex-coated beads. The confluent MBMEC
monolayer displays a cobblestone appearance when grown on
collagen-coated surfaces. The cells were positive for CD146 [48],
demonstrating their endothelial origin, and also expressed S100B
[49] and GGT [46], indicating their brain origin. MBMEC
exhibited an average TEER value of 250–300 V/cm
2 [50]. The
cells also exhibited the typical characteristics for brain endothelial
cells expressing tight junctions and a polarized transport of
rhodamine 123, a ligand for P-glycoprotein [51].
E. coli strain and invasion assay. E44, a rifampin-resistant
derivative of E. coli K1 strain RS218 (serotype 018:K1: H7) [1,52],
was grown for 15 h at 37uC in L broth in the presence of rifampin
(100 mg/ml). To test the effects of nicotine on E. coli invasion,
MBMEC were subcultured in tissue culture plates and 1610
-5 to
10
27 M of nicotine tartrate was pre-incubated with MBMEC in
RPMI-1640 medium. After exposure to nicotine, cell cultures were
examined under a microscope. E. coli invasion assays were
performed as described previously [1,8]. The released
intracellular bacteria were enumerated by plating on sheep
blood agar plates. Cell viability was routinely verified by the
trypan blue staining assay. Results were expressed as relative
invasion (percentage of invasion in comparison to that of untreated
MBMEC). The a7 antagonist MLA, Ca
2+ pathway inhibitors
KN93, TFP, and EGTA were used to examine the role of a7i n
nicotine-enhanced E. coli invasion. The inhibitors were incubated
with the MBMEC monolayers for 1h at 37uC before addition of
bacteria. All inhibitors were present throughout the invasion
experiments until the medium was replaced with experimental
medium (EM) containing gentamicin. The effect of these inhibitors
on E. coli and MBMEC was examined by bacterial colony
counting and trypan blue staining methods, respectively.
PMN transmigration. Mouse PMNs were isolated accord-
ing to standard techniques from heparin anticoagulated venous
blood of 8-10 week-old mice for both a7 nAChR wildtype and KO
mice [27]. The isolated mouse PMN were 99% pure as indicated
by immunostaining with an antibody against the Ly-6G neutrophil
marker. Leukocyte transmigration assays were performed as
described previously [27,53–54] with modification. To test the
effects of nicotine on PMN transmigration, MBMEC were sub-
cultured on transwell filters (3.0-mm pore size, 6.5mm diameter)
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monolayer was confirmed by light microscopy before the start of
the assay. E44 (10
5 CFU/ml) was added to the lower chambers
and incubated for 2 h. Then, PMN (1610
6 cells) were added to
the upper chamber and allowed to migrate over for 4 h. At the end
of the incubation, migrated PMN cells were collected from the
lower chamber and counted as described previously [27]. All
experiments were performed with triplicate wells. For inhibitions
of PMN transmigration, cells were incubated with inhibitors for 1
h before E44 stimulation. All inhibitors were present throughout
the experiment. The BMEC monolayers on Transwell filters were
monitored before and after PMN migration by measuring trans-
endothelial electrical resistance (TEER) changes in the endothelial
cell monolayer using a Millipore ERS apparatus, according to
manufacturer’s instruction.
PMN binding. PMN adhesion assays were performed as
described previously [27,55]. Briefly, mouse BMEC monolayers
on 96-well plates were incubated with 1610
25 to 10
27 Mo f
nicotine tartrate for 48 h and stimulated with E44 cells (10
5/ml at
the beginning) for 2 h in EM. After incubation, monolayers were
washed 4 times with PBS. Each well received 2610
5 PMN (0.2 ml)
and was incubated for 90 min at 37uC. Then, cells were washed 5
times and fixed with 4% paraformaldehyde in PBS. Assays were
performed in triplicate wells. Next, the mouse PMNs were stained
with a mouse PMN-specific antibody against Ly-6G (Gr-1) IgG/
FITC [56] and the numbers of PMN were counted under a
fluorescence microscope. Fifteen microscope fields were randomly
selected from 3 wells for each treatment to count the number of
adherent leukocytes.
Immunofluorescence microscopy. MBMEC were grown
in eight-well chamber slides coated with collagen. After
treatment, MBMEC were washed with PBS and fixed with
4% paraformaldehyde or 95% ethanol (vol)–5%-acetic acid (vol)
(for ZO-1) for 10-30 min at room temperature. After additional
washes with PBS, MBMEC were blocked with 5% BSA in PBS
for 30 min. Then, cells were stained with rhodamine-conjugated
a-BTX and FITC-conjugated antibodies against GGT (rabbit),
CD146 (mouse), S100B (rabbit) and ZO-1 [51]. The cells
were then mounted with mounting medium containing DAPI
(from Vector). Samples were examined under a Leica
fluorescence microscope at the Congressman Dixon Cellular
Imaging Core Facility, Children’s Hospital Los Angeles. All
pictures were taken using the same parameters to ensure that
the fluorescence strength of each treatment could be compared
and calculated.
Immunoblotting analysis. To assess protein expression in
MBMEC, WT or KO cells were grown on 60 mm plates.
Confluent MBMEC monolayers were incubated with 10 mM
nicotine for different time points or different concentrations of
nicotine (0.1–10 mM) for 48 h, stimulated with or without E44
(10
6 CFU/ml) for 4 h. After completion of the incubation, total
protein was extracted with SDS buffer, heated and subjected to
SDS-polyacrylamide gel electrophoresis (SDS–PAGE) as described
previously [23]. Total protein was transferred to nitrocellulose
membranes by semi-dry blotting. After blocking with 5% milk in
PBST (PBS containing 0.1% Tween20, Sigma) for 1 hour,
membranes were probed with antibodies against a7 nAChR
(rabbit Ab, 1 mg/ml, Genescript), ZO-1 (rabbit Ab, 2 mg/ml,
Invitrogen), occludin (mouse Ab, 2 mg/ml, Invitrogen), and
b-actin (rabbit Ab, 0.1 mg/ml, Santa Cruz Biotechnology,) for 2
h. The washed membranes were incubated with a HRP-
conjugated secondary antibody for 1h and then visualized using
an enhanced chemiluminescence procedure (Roche Applied
Science, Indianapolis, IN).
Transendothelial permeability assay
Transendothelial permeability assays were performed as
described previously by measuring the passage of HRP through
the confluent monolayer with transwell insert culture chambers
[57]. Confluent WT and KO MBMEC monolayers on transwell
inserts were exposed to 10 mM nicotine for 48 hours. After E44
stimulation (10
6/ml within 0.2 mL) in the upper wells for 2 hours,
the lower chamber was also refilled with fresh EM. Then, HRP
(3 mg/ml) was added into each well. Twenty ml of EM was
withdrawn from each lower chamber every hour. Ten ml was
transferred to a 96-well ELISA plate, and the other 10 ml was
diluted and plated on agar blood plate for bacteria number
counting. After sample collection at different time points (0, 1, 2, 3,
4, 5 and 6 h), the experimental medium was subjected to the
ELISA assay using TMB substrate (from KPL, Gaithersburg,
MA). HRP activity was determined spectrophotometrically at
450 nm after adding the stop solution.
Mouse model of E. coli meningitis. Nicotine exposure was
executed from day 8 to day 10 by feeding twice daily (free base
2.1 mg/kg body weight/day). For the study on chemical blockage
of a7 nAChR, WT mice were exposed to nicotine (6–8 mice each
group) and treated with or without the a7 antagonist MLA. MLA
treatment started from day 8 to day 10 by intraperitoneal injection
(10 mg/kg body weight) daily before the first nicotine exposure.
Homozygous (a7
+/+, a7
-/-) and heterozygous (a7
+/-) mice were
exposed to nicotine as mentioned above. At 10 days of age, all
pups received E. coli K1 strain E44 (2610
5 CFU) by intra-
peritoneal injection. Fifteen hours after E. coli inoculation, Evans
blue (EB) was injected intraperitoneally (50 mg/g body weight).
Three hours after receiving EB, animals were anaesthetized with
ketamine and lidocaine, and blood samples were collected from
heart puncture for bacterial culture using sheep blood plates. After
perfusion from heart puncture with 20 ml PBS [58], the skull was
opened. CSF samples were collected by washing the brain tissues
with 100 ml of PBS, and then by washing the cerebral ventricles
and cranial cavity with another 100 ml of PBS as described
previously [27,33]. CSF samples containing more than 10
erythrocytes per ml were discarded as contaminated samples
[27,33]. The brain tissues were cut into two halves. One half of the
brain was put into a tube with 200 ml formamide to extract the EB.
Subsequently, the optical density of the extracted EB was
measured at 620 nm by spectrophotometry according to Zhang
X et al [59]. The other half of the brain was mashed and diluted for
bacterial culture with blood plates. For bacteria counting in CSF,
20 ml CSF samples were taken and diluted for bacterial culture
with blood plates. For PMN counting in CSF, 50 ml CSF samples
were stained with a FITC-conjugated rat anti-mouse Ly-6G (Gr-1)
antibody and counted under fluorescence microscopy. Albumin
concentrations in CSF samples were determined using a mouse
Albumin ELISA kit from Bethyl laboratories (Montgomery, TX)
according to the manufacturer. CSF samples were stored in
280uC for cytokine assays.
Mouse tobacco smoking exposure. Neonatal WT mice
were divided into two groups (control and treatment, 7 mice each
group). A TE-10 mouse smoke system with whole body exposure
(Teague Enterprise, Davis, CA) was used with low tar research
cigarettes (3R4F, Kentucky Tobacco Research& Development
Center) [60] The mice at the age of 4 days were exposed to a
mixture of main stream smoke (puffed smoke, 5%) and side stream
smoke (smoke emitted by burning end of a cigarette, 95%) for
2 hours per day and a total of 7 days. Smoke particle con-
centration (TSP) in the chamber was maintained at 4562 mg/m
3.
At 10 days of age, E. coli meningitis was induced as described
above.
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16 h after infection, fixed in 10% buffered formalin for 24 h,
embedded in paraffin, and sections with 5 mm thickness were
prepared. Tissue sections were stained with hematoxylin and
eosin, and examined under a microscope to investigate histological
alterations in the brain. Immunofluorescence staining of tight
junction molecules occludin and ZO-1 was performed as described
by Fo ¨rster et al [61]. The prepared sections were incubated with
antibodies against occludin (2 mg/ml) or ZO-1 (2 mg/ml) in 1%
BSA at 4uC overnight, followed by a rhodamine-conjugated
second antibody combined with a FITC conjugated mouse
antibody against CD146 (1 mg/ml) in 1% BSA for 1 hour.
Samples were washed with PBS and mounted with mounting
medium containing DAPI (Vector Laboratories, Burlingame, CA).
For a-BTX-staining of a7 nAChR in mouse brains, tissues sections
were incubated with rhodamine-conjugated a-BTX for 1 hour,
and mounted as described above. Photographs were taken under a
Leica fluorescence microscope as described above. To examine
neuron injury, the TUNEL assay was performed according to the
manufacturer’s protocol (Millipore, Chemicon, Billerica, MA).
Then, the tissue sections were stained with a FITC-conjugated
mouse antibody against neuron-specific nuclear protein (NeuN)
(eBiosciences), and counterstained with DAPI. Image fluorescence
quantification analysis was performed with program MetaMorph
(Version 7.7.3.0) for tight junction molecules (ZO-1 and occludin)
and TUNEL assays. For each treatment, 5-6 mouse brains were
sectioned and stained.
Cytometric Bead Array (CBA) assay. The levels of cyto-
kines in CSF, including IL-1b, IL-6, TNF-a, MCP-1 (CCL2),
MIP-1a (CCL3), and RANTES (CCL5), were examined using the
CBA assay (BD Biosciences, San Diego, CA) according to the
manufacturer’s protocol. Lyophilized protein (analyte) standards
were multiplexed to contain a mixture of predetermined amounts
of all analytes, and were used to prepare 9 serial dilutions,
providing a range of concentrations from 10 to 2,500 pg/ml.
Aliquots (50 ml each) of the analyte standards or experimental
samples were mixed with 50 ml of premixed capture beads and
incubated at room temperature (RT) for 1 h. Each set of capture
beads is coated with a monoclonal antibody against a single
analyte, and a mixture of 6 bead sets was combined to capture the
6 different analytes per sample. Next, we combined 6 PE-labeled
detection antibodies against epitopes distinct from those recog-
nized by the antibody-coated beads. Fifty microlitter of the mixed
PE-labeled detection reagent was added to each sample and
incubated for 2 h at RT in the dark. PE-conjugated detection
antibodies stain beads proportionally to the amount of bound
cytokine. Excess detection antibodies were removed by washing.
The data were collected on an LSRII flow cytometer using DIVA
software (BD Biosciences). FCAP software (BD Biosciences) was
used to fit standard curves to the data obtained from the analyte
standards and to calculate absolute concentration values for each
of the 6 measured analytes from their respective standard curves.
Analysis of adhesion molecule expression in vitro and in
vivo. To assess the surface expression of adhesion molecules in
vitro, a7
+/+ and a7
-/- MBMEC were grown in 96-well plate,
incubated with or without 10 mM nicotine for 48 h, and then
stimulated with or without E44 (10
6 CFU/ml) for 4 h. At the
completion of incubation, cells were washed twice with PBS, fixed
with 4% paraformaldehyde, and then blocked with PBS containing
5% BSA for 30 min. Cells were incubated with primary antibodies
against ICAM-1 (rabbit Ab, 1 mg/ml, Abbiotec) and CD44 (mouse
Ab, 1 mg/ml, Santa Cruz Biotechnology) at 4uC overnight. After
washing, the cells were incubated with a HRP-conjugated
secondary antibody for 1 h at room temperature. Liquid TMB
substrate (KPL) was used for ELISA. For each assay, an isotype-
matched controlantibody wasused inplaceof the primary antibody
in three wells, and this background was subtracted from the signal.
Analysis of adhesion molecules in CSF samples was performed by
the same method using 96-well ELISA plates.
Measurements of intracellular [Ca
2+]. To examine the
role of a7 nAChR in E. coli induced calcium signaling, intracellular
calcium flux in MBMEC was evaluated according to Kim KV et al.
and Sukumaran SK et al [22,62] with modifications. Briefly,
MBMEC were cultured in Glass Bottom Culture Dishes (MatTek,
Ashland, MA) in culture medium to 80% confluence with or
without nicotine exposure (10 mM) and MLA incubation (1 mM)
for 48 hours. Monolayers were washed with phenol-red-free
HBSS and then incubated for 60 min with 4 mM Fura-2 AM
and 0.04% Pluronic-127. Cells were then washed with phenol-red-
free HBSS 2 times and incubated in this buffer for an additional
20 min. Then, cells were monitored for 10 min at 4 seconds
intervals while recording the intensities of fluorescence at 340 nm
and 380 nm. At the 2 min time point, E44 (1610
8 CFU) were
added to stimulate MBMEC, and changes in intensities at 340 nm
and 380 nm were measured. These Fura-2 AM experiments were
performed on a Nikon Instrument Diaphot TMD 300 inverted
microscope (Melville, NY), using a Nikon Fluor 406/1.3 NA
Ph4DL oil immersion objective lens. A Hamamatsu Corp.
(Bridgewater, NJ) ORCA-100 (C4742–95-12NR) 12-bit digital
camera was operated in 464 binning mode, with typical exposure
times of 100–200 ms/channel. The microscope was equipped with
a Ludl Electronics Products Ltd. (Hawthorne, NY) Mac2000 XYZ
stage and a focus controller. The imaging rig was controlled by
MetaMorph 4.5 (Universal Imaging Corp., Downingtown, PA).
Changes in [Ca
2+] were expressed as the F340:F380 ratio, where
F340 and F380 were Fura-2 fluorescence intensities obtained at
340 nm and 380 nm excitation wavelengths, respectively.
Statistical analysis. For the analysis of the in vitro data,
ANOVA and covariates followed by a multiple comparison test
such as the Newmann-Keuls test were used to determine the
statistical significance between the control and treatment groups.
Software GraphPad Prsim 5.0 was used for analysis of data from
animal experiments. P,0.05 was considered to be significant.
Database
The protein access codes in Swissprot database are listed as
follows: a7 nAChR, Mus muscularus, Q9JHD6; ZO-1, Mus
muscularus, P39447; occludin, Mus muscularus, Q61146; CD44,
Mus muscularus, P15379; ICAM-1, Mus muscularus, P13597; CD146,
Mus muscularus, Q8R2Y2; S100B, Mus muscularus, P50114; GGT,
Mus muscularus, Q60928; TNFa, Mus muscularus, P06804; IL-1b,
Mus muscularus, P10749; IL-6, Mus muscularus, P08505; MCP-1,
Mus muscularus, P10148; MIP-1a, Mus muscularus, P10855;
RANTES, Mus muscularus, P30882.
Supporting Information
Figure S1 Isolation and characterization of WT and KO
MBMEC. (A) Images of MBMEC after isolation and purification
using UEA-coated beads under light microscope (DIC). These
cells (a7
+/+ and a7
-/-) were at passage 3. The WT and KO
MBMEC were stained with FITC-conjugated antibodies against
mouse CD146, GGT, S100B, and rhodamine-conjugated-a-BTX,
respectively. The WT and KO MBMEC were also stained with a
rabbit anti-ZO-1 Ab (FITC-conjugated) to show the formation of
tight junctions. All bars are 25 mm. (B) Immunoblotting analysis
of a7 nAChR from MBMEC (WT and KO). b-actin was used as
an internal loading control. (C) WT and KO mouse brain cortex
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BTX. Images are 1006. The squared areas were enlarged to show
the details of a-BTX staining. Images are 2006.
(TIF)
Figure S2 Effects of chemical and genetic blockages of
a7 nAChR on pathogenicities of E. coli K1. (A-B) Bacterial
loads in the CSF of mice under different settings: (A) WT:
Treatment with NT or MLA; and (B) WT and KO: Exposure to
NT. (C-D) Flux of albumin into CSF of mice under different
settings: (C) WT: Treatment with NT or MLA; and (D) WT and
KO: Exposure to NT (n=6–8). WT mice without treatment (NT
or MLA) served as the controls *P,0.05, **P,0.01.
(TIF)
Figure S3 Nicotine increased pathogenicities of E. coli
K1 in WT and heterozygous (HZ) (+/-) mice. E. coli
meningitis was induced in neonatal mice under 4 different settings
(n=6–7) (I: WT; II: WT+NT; III: HZ; IV: HZ+NT). (A)
Bacteremia; (B) Bacterial loads in the brains; (C) Bacterial loads
in the CSF; (D) Recruitment of PMN into the CSF; and (E) Flux
of albumin into the CNS. *P,0.05, **P,0.01.
(TIF)
Figure S4 Tobacco smoking (TS) increased pathogenic-
ities of E. coli K1 in the neonatal meningitis model. E. coli
meningitis was induced in neonatal mice under two different
settings (n=7) [I: WT (Control); II: WT+TS]. (A) Bacteremia; (B)
Bacterial loads in the brains; (C) Bacterial loads in the CSF; (D)
Recruitment of PMN into the CSF; and (E) Flux of albumin into
the CNS. *P,0.05, **P,0.01.
(TIF)
Figure S5 Effects of blockages of a7 nAChR on NT- and
E44-induced tight junction (TJ) disruption.( A-C) Immu-
noblotting analysis of occludin, ZO-1 and a7 nAChR under
different experimental settings: (A) WT MBMEC +NT (0.1–
10 mM for 48 h); (B) WT MBMEC+NT (10 mM for 0-72h); (C)
WT MBMEC+NT (10 mM for 48h)+MLA (0–10 mM for 48 h). In
(A-C), b-actin was used as an internal loading control. (D)
Fluorescence-based quantification of ZO-1 expression in WT and
KO mouse brain cortex with or without NT exposure upon E44
infection (n=5–6). The WT mouse control without any treatment
was taken as one fold. (E) Immunostaining of TJ molecules in
mouse brain cortex with or without NT exposure under different
settings (I: CON: No treatment; II. E44; III: E44+NT). The tissue
section was stained with antibodies against ZO-1 (rhodamine-
conjugated) and CD146 (FITC-conjugated). DAPI staining was
used to show the structures of brain cortex. Images are 2006.
(TIF)
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